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Isolated rat kidney mitochondria are able to generate xtraordinary amounts of adenosine. About one-third of the ade- 
nosine formed only results from the degradation of adenine nucleotides. Pyridine nucleotides may contribute to adenosine 
formation. Nevertheless, there must be an additional, as yet unidentified, acid-insoluble compound in mitochondria which 
is able to form a significant portion of adenosine. 
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1. INTRODUCTION 
Several studies have shown that ischemia causes 
mitochondrial dysfunction [ 1,2]. At ischemia, the 
adenine nucleotide contents of heart [3,4] and liver 
mitochondria [5] decrease. The mechanism of this 
decrease is not at all understood. Phosphate- 
induced efflux [6] as well as intramitochondrial 
degradation of nucleotides has been suggested 
[5,7]. In previous studies we could demonstrate 
that isolated mitochondria of rat kidney generate 
extraordinary amounts of hypoxanthine and in- 
osine [S]. 
The present study was designed to identify the 
source of these catabolites. The results provide 
evidence that adenosine is an obligatory metabolite 
of adenine nucleotide degradation and that kidney 
mitochondria are able to form extraordinary 
amounts of adenosine, additionally. 
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2. MATERIALS AND METHODS 
Mitochondria were isolated as in [2]. The preparation 
medium contained 210 mM mannitol and 70 mM sucrose buf- 
fered at pH 7.4 with traces of Tris. The incubation experiments 
with mitochondria were performed in this medium at 37°C for 
the time periods indicated using about 15 mg protein per ml, 
22 PM carboxyatractyloside and 4 PM oligomycin. Where in- 
dicated, coformycin was used at 1.3 PM. 
Mitochondria were extracted with 0.1 vol. ice-cold perchloric 
acid (0.33 M). The acid-soluble fraction was neutralized with 
0.15 vol. of a solution containing 2 M KtCO3 and 0.5 M tri- 
ethanolamine. 
Nucleotides, nucleosides and bases were determined by using 
a Hewlett Packard (Vienna) 1090 M HPLC system consisting of 
a ternary solvent delivery system, diode array detector, auto- 
sampler and LC workstation. A guard column (2.1 x 20 mm; 
10 /rn ODS material: Academy of Science, Berlin, GDR) and a 
microbore analytical column (2.1 x 100 mm; 5 pm ODS Hyper- 
sil: Shandon), both manufactured by Hewlett Packard, were 
used. Chromatography conditions: equilibration period, 10 min 
using 7% solvent B; linear gradient from 7 to 100% solvent B, 
taking 30 min; flow rate, 0.1 ml/min. Solvent A: 10 mM 
NHdHrPOd, 0.5 mM tetrabutylammonium bromide (pH 5); sol- 
vent B: 10 mM N&HrP04, 2 mM tetrabutylammonium 
bromide (pH 6.5), 25% (v/v) acetonitrile. 
Protein determinations were made by a Biuret method with 
human serum albumin as standard [2]. Coformycin, oligomycin 
and carboxyatractyloside were from Calbiochem AC (Giessen), 
Serva (Heidelberg) and Boehringer (Mannheim), respectively. 
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Table 1 
Balance of adenine nucleotides and of catabolites in kidney 
mitochondria 
Time 
(min) 
Nucleotides 
(nmol/mg) 
Catabolites 
(nmol/mg) 
I 0 5.37 f 0.07 2.7 + 0.7 
II 60 0.66 f 0.08 19.7 * 0.7 
III II-I 4.69 + 0.05 16.6 * 1.17 
Nucleotides: sum of AMP, ADP and ATP; catabolites: sum of 
hypoxanthine, inosine and adenosine; incubation time, 60 min; 
n = 3; SD; further details, see section 2 
3. RESULTS 
Table 1 shows the balance of the extent of 
adenine nucleotide degradation and of the forma- 
tion of hypoxanthine, inosine and adenosine. The 
sum of AMP, ADP and ATP in mitochondria 
decreased by 4.7 nmol/mg protein when mitochon- 
dria were incubated for 60 min. The sum of hypox- 
anthine, inosine and adenosine increased during 
this incubation period by 16.6 nmol/mg protein. 
Consequently, adenine nucleotides were only 
responsible for 28% of the catabolites formed. 
Fig. 1 demonstrates two typical HPLC 
chromatograms. In the absence of coformycin, the 
main catabolites were hypoxanthine and inosine. 
However, adenosine was the main catabolite in the 
presence of coformycin. 
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4. DISCUSSION 
Our results indicate that isolated mitochondria 
of rat kidney are able to form extraordinary 
amounts of nucleotide catabolites. The ex- 
periments with coformycin, a tight-binding in- 
hibitor of adenosine deaminase [9], show that 
adenosine is an obligatory metabolite and that, as 
expected, guanine nucleotides do not contribute 
markedly to the amount of catabolites formed. The 
main pathway of adenosine formation may pro- 
ceed via AMP and 5 ‘-nucleotidase. 
The extraordinary amount of adenosine formed 
could not be explained on the basis of the extent of 
adenine nucleotide breakdown. The nature of the 
additional compound(s), containing adenosine as a 
constituent, remains to be established. The 
pyridine nucleotides may be partly responsible for 
the formation of adenosine. In rat liver mitochon- 
dria, the content of NAD(P) and NAD(P)H 
amounts to about 4.5-6.5 nmol/mg protein 
[lO,ll]. The degradation of NAD(P) includes the 
formation of ADP-ribose and AMP, respectively 
[IO- 121. In liver mitochondria, mono(ADP- 
ribosylation) of proteins by NAD has been de- 
scribed. This potential source of AMP amounts to 
about 0.2 nmol/mg protein only [12]. 
Our HPLC analysis yielded no evidence for the 
existence of any low molecular mass, acid-soluble 
compound which could be a precursor of 
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Fig. 1. HPLC chromatograms of extracts from incubated kidney mitochondria. (A) Control, (B) with coformycin; incubation time, 
15 min; Hyp, Ino and Ado denote hypoxanthine, inosine and adenosine, respectively; further details, see section 2. 
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adenosine. Recently, in rat heart mitochondria a 
labelled acid-insoluble compound, presumably 
either RNA or polyA, was detected after perfusion 
of Langendorff rat heart with [i4C]adenosine [13]. 
A cyclic process consisting of polyA synthesis by 
ATP polymerase and polyA degradation by poly- 
nucleotide phosphorylase was supposed [ 141. By 
analogy, we assume the existence of a high 
molecular mass compound, which is responsible 
for the unusual amount of adenosine formed. 
In summary, kidney mitochondria are able to 
form extraordinary amounts of adenosine. 
Adenine and pyridine nucleotides may serve as 
sources of adenosine. A significant proportion of 
the adenosine formed results from the degradation 
of a hitherto unidentified, acid-insoluble com- 
pound. 
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